Oncologist and cancer outcomes researcher at the University of Oklahoma College of Medicine and the Stephenson Cancer Center || Passionate about improving cancer care || #PallOnc #GeriOnc
Happening now at #ASCOQLTY26: a “Quality Exchange” between this year’s Joseph Simone Quality Care Award winner Dr. Areej El-Jawahri and past recipients Dr. @ethanbasch.bsky.social and @drrobinyabroff.bsky.social. Session: https://bit.ly/4dyyjtL
The last session has ended, and our time at #ASCOQLTY26 has come to a close.
Thank you to our incredible attendees, speakers, and patient advocates for coming together to share actionable insights, elevate care delivery, and improve outcomes for the cancer community. 🧡
A huge ‘thank-you’ to all of our wonderful #ASCOQLTY26 Featured Voices for sharing their expertise on sessions and abstracts—and bringing so much joy and enthusiasm to the meeting! 💓
@ryannipp.bsky.social
Day 2 of #ASCOQLTY26 starts now! 🍳 Fuel up with a complimentary hot breakfast from 7:20-8:20 AM (ET) and jump straight into this morning’s poster session.
☕ Grab your coffee, build a plate, and join the discussion: https://bit.ly/3TmqXCW
Happening now at #ASCOQLTY26: Day 2 oral sessions are underway! 🗣️ Experts are on stage discussing the next frontier of oncology care, from debated AI workflows to innovative survivorship tools. https://bit.ly/4hEqHIO
Learning about “Delivering Value in Everyday Oncology Care” right now at #ASCOQLTY26 in a session chaired by Dr. Ryan Huey and Dr. Hari Nathan: https://bit.ly/4jdqFc4
Congratulations to Areej El-Jawahri, MD, FASCO, winner of the Joseph V. Simone Quality Care Award! 🏆This honor recognizes her multiple, significant & enduring contributions to the quality and safety of cancer care. Thank you for your leadership! #ASCOQLTY26 Session: https://bit.ly/4zqN0aV
Finishing out the day at #ASCOQLTY26 with a complimentary reception and Poster Walks led by @ethicsdoctorp.bsky.social and Dr. Charles Jiang. Speaking with presenters and learning about their research + 🧀 = perfection! Learn more: https://bit.ly/4rVlgIF
Just finished presenting these new findings at #ASCOQLTY26
Industry payments to oncologists are associated with aggressive end-of-life care for patients with cancer.
Physician payments & end-of-life tx:
-Slight ⬆️ aggressive EOL care among those who received payments
-However, is this a function of 3' centers seeing more patients at later lines of tx?
-Need to clarify research support vs personal $
#ASCOQLTY26@thewonkologist.bsky.social@dusetzinas.bsky.social
Good morning, Boston! ☀️ #ASCOQLTY26 begins today!
Check out the sessions we will be covering today, and don’t forget to network at these events if you are in person. View the program or ASCO Meetings app to know when and where everything is happening: https://bit.ly/4d39BBJ
Read a short #ASCODailyNews profile on Dr. El-Jawahri and her emphasis on meeting the needs of patients with blood cancers and their caregivers: bit.ly/4ypiCh1
Congratulations to Areej El-Jawahri, MD, FASCO, winner of the Joseph V. Simone Quality Care Award! 🏆This honor recognizes her multiple, significant & enduring contributions to the quality and safety of cancer care. Thank you for your leadership! #ASCOQLTY26 Session: https://bit.ly/4zqN0aV
Oral Abstract Session A begins today with our Featured Voice Dr. @ryannipp.bsky.social welcoming everyone to #ASCOQLTY26! Check out what’s coming up in the session: https://bit.ly/4xpdLuK
✈️ En route to Boston (again!) for #ASCOQLTY26. Excited for my favorite meeting of the year! This @ascocancer.bsky.social 2 day conference has the latest science on cancer care delivery, symptom management, survivorship & the patient experience.
View full abstracts here: www.asco.org/quality/sear...
Higher county-level #MedicalDebt burden was associated with higher incidence of late-stage #Cancer across multiple cancer types, indicating a potential association between financial barriers and delayed diagnosis. ja.ma/4ib8W3N
Among patients with advanced #Cancer, clinical trial participation was low and increasingly shaped by physician- and practice-level factors rather than patient characteristics. ja.ma/4rVkOdr
Looking forward to sharing research during this week’s @ascocancer.bsky.social#ASCOQLTY26 !
Abstracts released today!
#financialtoxicity#navigation, #AI, #PalliativeCareshort.do/mDgb9z
The full 700+ abstracts for #ASCOQLTY26 are now available! Check out the latest science on quality, safety, and efficiency in #CancerCare delivery. Late-breaking abstracts will be released at 7 AM (ET) on their presentation day.
View the full abstracts here: https://bit.ly/3TwmKN6
We are honoring Dr. Areej R. El-Jawahri w/the 2026 Joseph Simone Quality Care Award at the upcoming #ASCOQLTY26!
Read about her journey & finding purpose in every aspect of cancer care: https://bit.ly/4ypiCh1
Announcing the ASCO Quality Care Symposium Featured Voices! Follow them before, during, and after the meeting for expert insights. Join the conversation w/ the official hashtag #ASCOQLTY26.
Registration is open: https://bit.ly/4hOQAEH
The best care is collaborative. 🤝 Don’t miss your chance to join the premier community dedicated to elevating the patient experience. Secure your spot at #ASCOQLTY26 in Boston and save with early bird rates by August 26: https://bit.ly/4c3z6Cc
Among patients with advanced #BiliaryTractCancer, durvalumab plus gemcitabine and cisplatin provided sustained 4-year overall survival benefit and a comparable safety profile vs placebo plus chemotherapy ja.ma/4ygxazN
The draft guideline recommendations for "Integration of Patient-Reported Outcomes in the Routine Care of Adults Undergoing Systemic Treatment for Cancer" are now available.
Help us refine these standards of care. Submit your feedback to us by July 22: https://bit.ly/4h3Xkzx
🚨 @ascocancer.bsky.social#ASCOQLTY26 provides an unparalleled opportunity to present data-driven science to help educate the oncology community & elevate care for all.
It's the LAST DAY to share your work & contribute to the conversation on patient-centered outcomes.
👉 www.asco.org/quality
Propel your career forward by submitting your research on topics ranging from Cost, Value & Policy to Tech. Innovation in Quality Care to #ASCOQLTY26 in Boston. Let’s advance quality cancer care together. ☕ Grab your Dunks & submit an abstract by June 16 at 11:59 PM (ET): https://bit.ly/49NsXsK
Among patients with early age–onset #ColorectalCancer in Texas, treatment delays longer than six weeks were associated with reduced survival, and language barriers represented a major risk factor contributing to delayed initiation of definitive therapy. ja.ma/3S1igN7
Older adults with advanced cancer mainly prioritized quality of life, but their treatment preferences were not associated with differences in survival, hospitalization, or adverse effects. ja.ma/3RwiJH5
Heading home from #ASCO26 today! Put two dates for @ascocancer.bsky.social Quality Care Symposium on your calendar:
🚨Abstracts are due in 2 weeks 6/16/2026
📆 #ASCOQLTY26 is Friday-Saturday 10/16-17/2026
See you in Boston!
www.asco.org/quality
Adding intraperitoneal paclitaxel to intravenous paclitaxel plus S-1 improved overall survival for #GastricCancer with peritoneal metastasis, with safety profiles comparable to intravenous-only therapy. ja.ma/3PA3fAX
Rural counties had stable or increased #LiverCancer (#HCC) incidence and mortality rates from 2001 to 2022, while urban counties experienced decreases, highlighting persistent rural-urban disparities. ja.ma/4nvw0ve
Elevate the quality, safety & efficiency of cancer care delivery—submit your research to #ASCOQLTY26. By presenting findings, you’re shaping a vibrant community of professionals dedicated to advancing patient care.
Prepare your submission: https://bit.ly/4cF0WUW
Older adults with advanced #cancer mainly prioritized quality of life, but their treatment preferences were not associated with differences in survival, hospitalization, or adverse effects.
ja.ma/4bf65m0
Analysis of US mortality data indicates breast cancer, lung cancer, and leukemia deaths decreased in people younger than 50, while #ColorectalCancer mortality rose to become the leading cancer death by 2023.
ja.ma/4qN1RII
Among #Medicare Advantage beneficiaries aged 75 years or older with #cancer, a lay health worker–administered telephone assessment reduced acute care use, including 68% lower odds of hospitalization, compared with standard care.
ja.ma/4plhA05
💬 Editorial: A randomized trial in community oncology clinics demonstrated that telephone-based lay health worker–administered PRO assessments for older adults with #cancer resulted in reductions in acute care utilization and lower mortality.
ja.ma/4ax5ygt
Among over 7000 patients with #cancer, higher baseline fatigue before systemic therapy was linked to an increased risk of severe, life-threatening, and fatal adverse events. ja.ma/4qmZtrt
Happening now!
@ryannipp.bsky.social
leads us in
@pallonccop.bsky.social
for a summary for #ASCOQLTY25! Join now!!
@tingtingzhang.bsky.social@fionnualacrowley.bsky.social@ericroeland.bsky.social@mazietsangmd.bsky.social@ascocancer.bsky.social@darcyburbage.bsky.social@rsedhom.bsky.social
I am honored to give the #ASCOQLTY25 Simone Award to @drrobinyabroff.bsky.social today. Dr Yabroff has a profound impact as a researcher, policy advocate, & mentor. It's hard to find someone in health services research that hasn't been positively influenced by her intellect, wit, & warmth.🏆
Excellent first session this morning at #ASCO Quality Care Symposium: “Partners in Care: Building Bridges Through Shared Decisions.”
meetings.asco.org/meetings/202...#ASCOQLTY25#CancerCare#CancerResearch@ascocancer.bsky.social
The 2025 @ascocancer.bsky.social Quality Care Symposium #ASCOQLTY25 will feature >600 abstract presentations covering the latest implementation science and the entire spectrum of health services research.
📖 Review abstracts today!
✈️ Join us this weekend in Chicago
meetings.asco.org/abstracts-pr...